CClinicalTrials.gg
CompletedNCT04674995STROBEUpdated Apr 4, 2022

Stent Versus Balloon Dilatation in Patients With Tracheal Benign Stenosis

An observational study in Tracheal Stenosis, sponsored by University of Modena and Reggio Emilia. Completed. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2022-04-04.

Sponsored by University of Modena and Reggio Emilia · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
66
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This is a retrospective, observational cohort study carried out in two operative Units of the University Hospital of Modena (Italy): the Diagnostic and Interventional Bronchoscopy Unit (Unit A) and the Otolaryngology Unit (Unit B). The two units have different protocols routinely applied to treat tracheal benign stenosis. In Unit A, endoscopic treatment is performed through mechanical dilatation via rigid bronchoscopy and further stent placing while in Unit B the endoscopic treatment is performed through balloon dilatation via direct laryngoscopy. The primary purpose was to compare the efficacy of the two technique on tracheal stenosis treatment over time. Patients were defined as "cured" if during the 2 years after 12 months since the last intervention they did not present any of the following: respiratory symptoms, need for a re-intervention or stenosis instability.

02

Conditions studied

  • Tracheal Stenosis
03

In context

Tracheal Stenosis

37 studies on the registry are indexed under Tracheal Stenosis; 11 are open to participants now.

This study's enrollment of 66 is below the median of 78 across 12 observational studies indexed under Tracheal Stenosis.

Browse Tracheal Stenosis studies →

Lead sponsor

University of Modena and Reggio Emilia is the lead sponsor of 61 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

We collected clinical, endoscopic and radiological data of patients with benign tracheal stenosis admitted in two operative Units of the University Hospital of Modena (Italy): The Diagnostic and Interventional Bronchoscopy Unit (Unit A) and the Otolaryngology Unit (Unit B) from November 2012 to November 2017

Inclusion criteria

  • age >18 years,
  • exclusion from resection-anastomosis surgery after multidisciplinary evaluation,
  • Cotton Meyer > grade II,
  • follow-up of at least 3 years after endoscopic surgery,
  • no previous tracheal surgery.

Exclusion criteria

Exclusion Criteria:

  • age > 80,
  • stent intolerance which requires removal in the first year after endoscopic treatment,
  • performance status > 2,
  • end-stage chronic pulmonary disease,
  • life-threatening stenosis that needs urgent endoscopic treatments,
  • any neoplastic stenosis of the airways,
  • dynamic etiology of tracheal benign stenosis (excessive dynamic airway collapse, tracheobronchomalacia).
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
66 participants (actual)
Patient registry
No

Groups and cohorts

  • Stent

    Patients with tracheal stenosis treated with stent placement via rigid bronchoscopy.

    Procedure: Stent placement

  • Balloon dilatation

    Patients with tracheal stenosis treated with balloon dilatation via laryngoscope.

Interventions

  • ProcedureStent placement

    All interventional procedures have been performed in the operating room with a Dumon rigid bronchoscope under general anesthesia. Neodymium-doped yttrium aluminium garnet laser photoresection was performed at 15-30 watts and pulse duration of 0.5-1.0s whenever indicated. A silicone stent was placed.

06

What researchers measure

Primary outcomes

  1. Re-stenosis rate over time

    Patients were defined as cured if during the 2 years after 12 months since the last intervention they did not present any of the following: respiratory symptoms, need for a re-intervention or stenosis instability.

    Time frame: 36 months

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 4, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04674995
Lead sponsor
University of Modena and Reggio Emilia
Responsible party
Alessandro Marchioni (Principal Investigator, University of Modena and Reggio Emilia) — Principal investigator
First posted
Dec 19, 2020
Start date
Nov 1, 2012
Primary completion
Nov 1, 2017
Completion
Dec 1, 2020
Last update
Apr 4, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion